D.C. medical cannabis market grows in July, driven by manufacturing sales despite dispensary plateau
D.C.’s medical cannabis market grew to $8.84 million in July, up over $400K from June and nearly double last year’s sales. Growth was driven by a $372K boost in manufacturing, while dispensary revenue stayed flat despite five new shops opening. Patient numbers rose by 4,500, with local registrations jumping from 13K to nearly 18K, though this translated to less than $70K in added sales. Out-of-state patient participation dipped, but still contributed about $500K. Sales rose across most product categories, even as average dispensary revenue fell.
- No ABC Board meeting this week. Next meeting Sept. 10, 2025.
- Last week’s meeting disposition.
Talbot County cannabis bill falls short
Talbot County’s proposed cannabis bill failed after debate over zoning, public safety, and regulatory issues, and lawmakers plan to revise it with adjustments for future consideration to better balance community and business interests.
- Maryland’s Psychedelics Task Force released an interim report detailing preliminary policy recommendations and research considerations, but it is actively seeking additional feedback from opponents of legalization to refine its final guidance.
Cannabis odor concerns fuel debate over legal retail sales
Concerns about downtown areas smelling of cannabis have sparked debate over whether legal retail sales will help regulate odor management or potentially worsen public perception and community complaints, as municipalities weigh policy options.
ICYMI: Law enforcement hits illegal cannabis shops in D.C. amid Federal crackdown
East Coast Roundup
New Jersey regulators launched a lab fraud probe after THC levels spiked in dispensary products, highlighting potential testing irregularities and ongoing concerns about product safety and consumer protection.
A Massachusetts audit revealed violations and mismanagement within the Cannabis Control Commission, prompting calls for stronger oversight, increased accountability, and improvements to regulatory processes.
A group of New York cannabis dispensary owners filed a lawsuit against state regulators after an admitted measuring error placed over 150 licensed shops too close to schools, seeking to protect their investments and maintain operations under the previous interpretation of the proximity rule.
A former illegal cannabis seller in Syracuse has been given the opportunity to operate legally, illustrating the potential for transitioning from the black market into regulated operations under state law.
Culture & More
A new study examines the effects of cannabis on cognitive function and mental health, exploring both potential benefits and risks associated with regular use and long-term consumption.
Santa Barbara hosts California’s largest cannabis farm, demonstrating large-scale cultivation methods, economic potential, and innovative approaches to commercial production.
Researchers continue to explore links between cannabis use and schizophrenia, seeking a deeper understanding of neurological and psychiatric outcomes connected to consumption patterns.
Cannabis brand Cookies is branching into the alcohol market with new product offerings, signaling diversification strategies and growth opportunities in complementary sectors.
Around the Country
Ohio’s cannabis industry continues to face challenges a year after legalization, including licensing complications, regulatory hurdles, and competitive market pressures affecting operators statewide.
Washington State’s post-pandemic cannabis market is experiencing slower growth, with sales leveling off as operators and consumers adapt to shifting demand and new market conditions.
Tribal hemp loopholes in Wisconsin are creating new opportunities for indigenous producers, while raising questions about regulatory consistency and oversight across different markets.
Michigan issued a recall for MCT oil cannabis products due to safety concerns, underscoring ongoing compliance challenges for manufacturers and distributors.
From the swamp
Former President Trump outlined his cannabis policy positions, highlighting partisan differences and signaling potential federal legislative priorities impacting the cannabis industry.
Federal cannabis reclassification could significantly benefit cannabis companies by reducing regulatory barriers and increasing market access nationwide. Reuters
Senator Jim Banks discussed safer banking access for cannabis businesses, emphasizing ongoing financial and regulatory challenges faced by operators across the country. Listen to the full interview at Ask A Pol Drugs.
